THE WOODLANDS

LGI Homes, Inc. Reports April 2024 Home Closings

Retrieved on: 
Friday, May 3, 2024
LGI Homes

THE WOODLANDS, Texas, May 03, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 505 homes in April 2024.

Key Points: 

THE WOODLANDS, Texas, May 03, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 505 homes in April 2024.
As of April 30, 2024, the Company had 127 active selling communities.

LGI Homes Opens New Community North of Seattle in Marysville

Retrieved on: 
Friday, May 3, 2024
Puget Sound, LGI Homes, History, Restaurant, Boeing, Village

MARYSVILLE, Wash., May 03, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the grand opening of The Village at Whiskey Ridge , a new community located in Marysville, Washington.

Key Points: 
  • MARYSVILLE, Wash., May 03, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the grand opening of The Village at Whiskey Ridge , a new community located in Marysville, Washington.
  • With five other builders selling homes within 1 mile of our community, LGI Homes at The Village at Whiskey Ridge is the most affordable.
  • We have three- and four-bedroom homes available for our customers starting in the $560,000 range, with all upgrades included in that price.
  • We have exceeded expectations by selling over 20 homes since we opened at the end of February,” said Zachary Penrod, VP of Sales of LGI Homes’ Washington division.

Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
Thursday, May 2, 2024
Shift, FDA, Albuminuria, Investment, Research, Webcast, Chronic kidney disease, Endothelium, PROGRESS, American College of Cardiology, ASN, ID, AAK1, Overalls, Heart failure, Treatment, Conference, HCM, Neuropathic pain, Quality of life, Diabetes, Patient, SGLT2 inhibitor, Travel, Diabetic ketoacidosis, Obesity, CKD, Marketing, Research and development, American College, Vessel, Insulin, Diabetes management, Inhibitor, NDA, Coagulation, Administration, Society, Lexicon, Risk, Growth, Lexicon Pharmaceuticals, Pharmaceutical industry

Net sales for the quarter were $1.1 million reflecting 63 percent growth from the previous quarter.

Key Points: 
  • Net sales for the quarter were $1.1 million reflecting 63 percent growth from the previous quarter.
  • Lexicon is initiating a Phase 3 study of sotagliflozin in HCM, with an expected study start mid-year 2024.
  • Results from Two Large US Integrated Health System
    Revenues: Revenues for the first quarter of 2024 were $1.1 million, primarily from the commercialization of INPEFA.
  • Lexicon management will hold a live conference call and webcast today at 5:00 pm ET / 4:00 pm CT to review its financial and operating results and to provide a general business update.

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

Retrieved on: 
Thursday, April 25, 2024
Collateral damage, Pain, NFR, AMIX, Intelligence, Disease, Nervous system, Application-specific integrated circuit, Pain management, ASIC, Ethanol, Medical imaging

As part of the agreement, Autonomix will work with NFR to assess its ASIC microchip and upgrade the chip to its second-generation in preparation for human clinical testing in the Company’s planned pivotal trial in 2025.

Key Points: 
  • As part of the agreement, Autonomix will work with NFR to assess its ASIC microchip and upgrade the chip to its second-generation in preparation for human clinical testing in the Company’s planned pivotal trial in 2025.
  • Additionally, NFR will evaluate a subsequent version meant to enable commercial production volumes.
  • Lori Bisson, Chief Executive Officer of Autonomix said, “This collaboration with NFR is an important step in the evolution of our technology and simple approach to a procedure for pain management and other indications.
  • Current approaches, primarily relying on opioids or invasive ethanol injections, can provide only limited relief and may lead to risky side effects.

Ring Energy Announces Timing of First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
Thursday, April 25, 2024
REI, Conference

THE WOODLANDS, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its first quarter 2024 earnings release and conference call.

Key Points: 
  • THE WOODLANDS, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its first quarter 2024 earnings release and conference call.
  • Ring plans to issue its first quarter 2024 earnings release after the close of trading on Monday, May 6, 2024.
  • The Company has scheduled a conference call on Tuesday, May 7, 2024 at 11:00 a.m.
  • Please reference the “Ring Energy First Quarter 2024 Earnings Conference Call”.

ChampionX Reports First Quarter 2024 Results

Retrieved on: 
Wednesday, April 24, 2024
Permian, TLM, Sale, Methane, Automation, Bacalhau, AI, Software, Pump, Partnership, Artificial intelligence, Water, ALP, IOC, Kingdom, Engineering, Tax, SLB, Montney, British Columbia, Artificial lift, Acquisition, Corrosion, Adjustment, ESP, Santos Basin, Natural gas

Net income attributable to ChampionX of $112.9 million, increased 78% year-over-year

Key Points: 
  • Net income attributable to ChampionX of $112.9 million, increased 78% year-over-year
    Adjusted net income of $96.4 million, increased 17% year-over-year
    Adjusted EBITDA of $191.7 million, increased 4% year-over-year
    THE WOODLANDS, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- ChampionX Corporation (NASDAQ: CHX) (“ChampionX” or the “Company”) today announced first quarter of 2024 results.
  • “During the first quarter of 2024, we generated revenue of $922 million, which decreased 3% year-over-year.
  • Given the pending acquisition of ChampionX by SLB, ChampionX has discontinued providing quarterly guidance and will not host a conference call or webcast to discuss its first quarter 2024 results.
  • Revenue from digital products was $56.8 million in the first quarter of 2024, up 8% sequentially, and down 1% year-over-year.

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Retrieved on: 
Wednesday, April 24, 2024
Nervous system, LIVE, AMIX

THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Lori Bisson, Chief Executive Officer of Autonomix, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar on Wednesday, May 1, 2024 at 3:20 PM ET.

Key Points: 
  • THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Lori Bisson, Chief Executive Officer of Autonomix, will present and discuss recent corporate events at LIVE!
  • with Webull Corporate Connect: Virtual Biotech Investment Webinar on Wednesday, May 1, 2024 at 3:20 PM ET.

Freight Technologies, Inc. Reports 30% Year-over-Year Revenue Growth and Strong Fr8Fleet Volumes for Q1 2024

Retrieved on: 
Monday, April 22, 2024
OTR, CFO, AI, USMCA, B2B

Fr8Tech achieved healthy revenue growth of 30% in Q1 2024 over the prior year with approximately $4.3 million in quarterly revenue.

Key Points: 
  • Fr8Tech achieved healthy revenue growth of 30% in Q1 2024 over the prior year with approximately $4.3 million in quarterly revenue.
  • This included a 278% year-over-year volume growth within the Fr8Fleet business to approximately 3,400 completed shipments.
  • Q1 is typically the slowest quarter of the year for freight activity, yet the Company was able to secure Fr8Fleet volume growth of 25% sequentially over Q4 2023.
  • The Company’s growth trajectory continues, not just with Fr8Fleet, but also with spot and cross-border shipments.

Lexicon Pharmaceuticals to Host 2024 Investor Day

Retrieved on: 
Thursday, April 18, 2024
Lexicon, Physician

THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024.

Key Points: 
  • THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024.
  • The event will be held in New York City from 9:00 a.m. to 12:00 p.m.
  • Business and scientific updates will be presented by Lonnel Coats, Lexicon’s chief executive officer; Jeff Wade, Lexicon’s president and chief financial officer; Alan Main, Ph.D., Lexicon’s executive vice president, innovation and chemical sciences; Tom Garner, Lexicon’s senior vice president and chief commercial officer; and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer.
  • The corporate presentations and panel discussion with renowned medical leaders will highlight Lexicon’s strategy and efforts to address major areas of need in:

Fr8App Selected by Grupo Solave for Cross-Border Logistics Services

Retrieved on: 
Wednesday, April 17, 2024
Blue agave, B2B, Tequila, USMCA

HOUSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT) (“Fr8Tech''), a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, announces its appointment as Solave's logistics solutions provider for cross-border operations.

Key Points: 
  • HOUSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT) (“Fr8Tech''), a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, announces its appointment as Solave's logistics solutions provider for cross-border operations.
  • Solave, recognized for its leadership in the Blue Agave market with achievements such as becoming a global leader in Agave Syrup production, a frontrunner in cultivating Blue Agave plants in Mexico, and a reputable Tequila producer for notable brands, aims to benefit from optimized logistics and supply chain efficiency through Fr8App’s platform.
  • "We are thrilled to take on the role of logistics solutions provider for Solave, applying our advanced platform and extensive network to meet their specific logistics needs," stated Javier Selgas, CEO of Fr8App.
  • “Tequila is one of the most popular spirits in the world, and sales are expected to grow approximately 6% annually over the coming decade.